My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

12.41 +0.27 (+2.22%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Tandem Diabetes Care Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
A Relative Strength Rating upgrade for Tandem Diabetes Care shows improving technical performance. 
Via Investor's Business Daily
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:... 
Via Benzinga
Analyzing Tandem Diabetes Care's Unusual Options Activity
On Thursday, shares of Tandem Diabetes Care (NASDAQ:TNDM)... 
Via Benzinga
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT... 
Via Benzinga
The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... 
Via Benzinga
Why Tandem Diabetes Care Stock Jumped Today
The stock is being added to the S&P MidCap 400 Index. 
Via The Motley Fool
Topics Stocks
45 Stocks Moving In Tuesday's Mid-Day Session
Gainers IronNet, Inc. (NYSE: IRNT) shares jumped 50.4% to $25.06 after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares jumped 32.6% to $4.2443. The company recently... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers Mechel PAO (NYSE: MTL) shares climbed 56.3% to settle at $5.00 on Tuesday. The company recently reported Q2results, including a 43% quarter-over-quarter revenue growth.... 
Via Benzinga
This Simple Thing Sent These 3 Nasdaq Stocks Soaring Tuesday
All it takes is money -- big money. 
Via The Motley Fool
Topics Stocks
Match Stock, Tandem Diabetes Lead Big Movers Due To S&P Index Changes
Match will join the S&P 500 and Tandem Diabetes the S&P MidCap 400. UniQure enters the SmallCap 600. 
Via Investor's Business Daily
Topics Stocks
23 Stocks Moving in Tuesday's Pre-Market Session
Gainers IronNet, Inc. (NYSE: IRNT) rose 89.7% to $31.61 in pre-market trading after jumping over 23% on Friday. Mechel PAO (NYSE: MTL) shares rose 36.6% to $4.37 in pre-market... 
Via Benzinga
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
5 Stocks Insiders Are Selling
When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to... 
Via Benzinga
Tandem Diabetes Care Stock Sees Improved Relative Strength
The Relative Strength (RS) Rating for Tandem Diabetes Care stock moved up into a higher percentile Monday, as it got a lift from 68 to 73. 
Via Investor's Business Daily
Tandem Diabetes Care, inc (TNDM) Q2 2021 Earnings Call Transcript
TNDM earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
Tandem Diabetes Care Announces Second Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to... 
Via Benzinga
Tandem Diabetes Care Announces Upcoming Conference Presentation
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care to Announce Second Quarter 2021 Financial Results on August 4, 2021
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technology Across Diverse Populations
From Tandem Diabetes Care, Inc.
Via Business Wire
2 Unstoppable Growth Stocks That Can Make You Richer Than Dogecoin
These two companies are less volatile than the cryptocurrency, and they offer better long-term prospects, too. 
Via The Motley Fool
Tandem Diabetes Care Announces Presentations Demonstrating Immediate and Sustained Real-World Improvements with Control-IQ Technology
From Tandem Diabetes Care, Inc.
Via Business Wire
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to... 
Via Benzinga
Tandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call Transcript
TNDM earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Applied Genetic (NASDAQ:AGTC) sha... 
Via Benzinga
Tandem Diabetes Care Announces First Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.